| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2014-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ce218403fa3b7966fc3ff81155e8a67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de048d0ed516fce055f3a55aa624f08d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90db11b09cfe9e63b7c66d83f5847fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc8e51d350b1714ad50ff256e5a0bbb7 |
| publicationDate |
2015-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9192667-B2 |
| titleOfInvention |
Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonist |
| abstract |
The present invention relates to the combination therapy of antibodies against human CSF-1R with a TLR9 agonist. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9879085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894963-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547761-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11692168-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11433131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11123294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9988458-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11498968-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10336830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512133-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10675358-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364304-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542335-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10030073-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287358-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10837018-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10072087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10077314-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110178-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663580-B2 |
| priorityDate |
2013-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |